Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-104.04	-140.11	-68.67
Graham Fair Price	-67.98	2.09	6.52
PEG	2424.68	0.35	-0.01
Price/Book	-20.19	3.02	3.79
Price/Cash Flow	21.81	-16.82	-21.51
Prices/Earnings	-638.14	-31.69	-4.29
Price/Sales	-24.48	18.59	24.62
Price/FCF	21.81	-16.82	-21.51
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	5.00	0.02	-0.02
Operating Margin	87.90	-0.23	-1.87
ROA	89.04	< 0.005	-0.07
ROE	-0.22	-0.02	89.19
ROIC	-0.18	-0.02	87.92
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	-0.02	-286.05
Dividends QOQ	-0.20	0.46	128.39
EBIT QOQ	-2.91	0.88	-69.91
EPS QOQ	-3.06	0.90	-70.76
FCF QOQ	-0.43	< 0.005	-99.34
Revenue QOQ	-0.65	0.03	-95.04
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	102.76	207.55	101.99
Days Sales Outstanding (DSO)	238.59	176.37	-26.08
Inventory Turnover	0.88	0.43	-50.49
Debt/Capitalization	0.42	0.41	-2.57
Quick Ratio	0.63	0.44	-30.39
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.93	2.85	-2.62
Cash	0.58	0.25	-56.17
Capex	-0.62	-0.07	88.90
Free Cash Flow	-0.52	-0.51	0.59
Revenue	0.45	0.46	2.93
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.87	0.91	4.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-8.24	-23.01	-179.22
Naive Interpretation	Member

06 - Financial Health · Bad

Rating